Sign in Pull a receipt

VTVT

vTv Therapeutics Inc.

Healthcare · Biotechnology

$229.75 sample

+2.58 (+1.14%) 1D

Market cap

$1.06T

Price as of

2026-10-29

Latest filing

8-K · 2026-10-27

Alerts

8

Price$229.75 +6.59% 3M daily closessample

239.89215.54

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 27SEC8-K filed: material event
Oct 22INSInsider sell: General Counsel
Oct 16INSInsider buy: General Counsel
Oct 13SECDEF 14A filed
Oct 02INSInsider sell: General Counsel
Sep 25INSInsider buy: Chief Financial Officer
Sep 18INSInsider sell: Chief Executive Officer
Sep 10INSInsider sell: Chief Financial Officer

Sign up to see the real VTVT record →

Company facts

SEC EDGAR registration

Name: vTv Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -3sample, -100 to +100
Reporting currency: USD

Who is positioning in VTVT

sample

Insiders: 30 insider transactions over 90 days, net selling, $176.5M
Congress: 3 members traded over 90 days
Institutions · 13F: 36 funds hold $14.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$49.0B +22.3% y/y

Q4 2024Q3 2026

Inventory$29.0B +19.5% y/y

Q4 2024Q3 2026

Accounts receivable$21.5B +15.2% y/y

Q4 2024Q3 2026

Total debt$54.6B +7.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $463.3B +3.9% 3M
Sample peer B: $197.5B -6.4% 3M
Sample peer C: $589.4B -0.6% 3M
Sample peer D: $727.6B +11.3% 3M
Sample peer E: $883.1B +6.1% 3M